Medivir: A solid quarter, but no news on financing – Q1(25) review
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Erbjudande: Krypto visar motståndskraft – här kan du just nu handla kryptovalutor avgiftsfritt (annons)

Pressmeddelande

Medivir: A solid quarter, but no news on financing – Q1(25) review

MFN Publicerad: Idag 10:02

Carnegie has published a new commissioned research report on Medivir.

To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/medivir/

Information
This is a press release from Carnegie. For information about Carnegie commissioned research, see https://www.carnegie.se/en/commissioned-research/, or contact our commissioned research team at [email protected].

Contacts
Visiting address: Regeringsgatan 56, Stockholm
Site: http://www.carnegie.se
Telephone: +46 8-5886 88 00

About Us
Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. Carnegie operates in six countries and has more than 800 employees.

Läses av andra just nu

Senaste nytt